Published in Curr Opin Immunol on February 01, 2003
Host immune system gene targeting by a viral miRNA. Science (2007) 5.10
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A (2004) 4.88
Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med (2003) 4.68
Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A (2009) 3.74
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med (2006) 2.30
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med (2005) 2.23
Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog (2007) 1.93
Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A (2003) 1.85
A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog (2008) 1.72
Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest (2005) 1.64
NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med (2007) 1.57
Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol (2005) 1.55
Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest (2012) 1.35
In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology (2007) 1.35
Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). Cancer Biol Ther (2009) 1.32
The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. J Exp Med (2006) 1.27
IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol (2012) 1.26
A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am J Hum Genet (2006) 1.22
Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog (2010) 1.22
Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells. Biol Blood Marrow Transplant (2014) 1.19
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection. J Virol (2010) 1.15
Natural killer cells and autoimmunity. Arthritis Res Ther (2003) 1.14
Population modeling of influenza A/H1N1 virus kinetics and symptom dynamics. J Virol (2010) 1.14
A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog (2013) 1.14
Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus. J Exp Med (2007) 1.13
Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics (2008) 1.12
NK cell response to vaccinia virus is regulated by myeloid-derived suppressor cells. J Immunol (2012) 1.11
Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study. PLoS One (2007) 1.09
Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics (2006) 1.07
The role of chemokines during herpes simplex virus-1 infection. Front Biosci (2008) 1.06
Altered distribution of mucosal NK cells during HIV infection. Mucosal Immunol (2011) 1.04
Natural killer cell responses to viral infection. J Innate Immun (2011) 1.03
Murine NK cell intrinsic cytokine-induced memory-like responses are maintained following homeostatic proliferation. J Immunol (2013) 1.01
Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. Biochemistry (2010) 0.99
Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors. J Immunol (2009) 0.98
Fish oil-fed mice have impaired resistance to influenza infection. J Nutr (2009) 0.96
Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus. J Virol (2009) 0.95
Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication. AIDS Res Hum Retroviruses (2015) 0.94
Activation mechanisms of natural killer cells during influenza virus infection. PLoS One (2012) 0.92
Memory CD8+ T cells specific for a single immunodominant or subdominant determinant induced by peptide-dendritic cell immunization protect from an acute lethal viral disease. J Virol (2012) 0.91
Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells. J Neuroimmunol (2008) 0.87
Killer Cell Lectin-like Receptor G1 Inhibits NK Cell Function through Activation of Adenosine 5'-Monophosphate-Activated Protein Kinase. J Immunol (2016) 0.86
Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3. Immunogenetics (2007) 0.86
NKG2D is required for NK cell activation and function in response to E1-deleted adenovirus. J Immunol (2010) 0.84
Early responses of natural killer cells in pigs experimentally infected with 2009 pandemic H1N1 influenza A virus. PLoS One (2014) 0.84
The Role of PPARs in Placental Immunology: A Systematic Review of the Literature. PPAR Res (2013) 0.84
Distal-less homeobox transcription factors regulate development and maturation of natural killer cells. Proc Natl Acad Sci U S A (2008) 0.83
Activation-specific metabolic requirements for NK Cell IFN-γ production. J Immunol (2015) 0.83
Two-compartment model of NK cell proliferation: insights from population response to IL-15 stimulation. J Immunol (2012) 0.82
Multiparametric analysis of host response to murine cytomegalovirus in MHC class I-disparate mice reveals primacy of Dk-licensed Ly49G2+ NK cells in viral control. J Immunol (2013) 0.82
Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells. Mediators Inflamm (2006) 0.81
Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis. J Neuroimmunol (2012) 0.81
Contribution of NK cells to the innate phase of host protection against an intracellular bacterium targeting systemic endothelium. Am J Pathol (2012) 0.80
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression. Neuro Oncol (2016) 0.80
Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression. Med Microbiol Immunol (2008) 0.79
Liver myofibroblasts from hepatitis B related liver failure patients may regulate natural killer cell function via PGE2. J Transl Med (2014) 0.78
Research on stress-induced apoptosis of natural killer cells and the alteration of their killing activity in mouse liver. World J Gastroenterol (2013) 0.77
Expansion of CD16 positive and negative human NK cells in response to tumor stimulation. Eur J Immunol (2014) 0.77
Function and subsets of dendritic cells and natural killer cells were decreased in gastric cancer. Int J Clin Exp Pathol (2014) 0.77
Natural killer cell function and dysfunction in hepatitis C virus infection. Biomed Res Int (2014) 0.77
The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection. Med Microbiol Immunol (2015) 0.77
Formyl peptide receptor suppresses melanoma development and promotes NK cell migration. Inflammation (2014) 0.76
Cytokine-Mediated Activation of NK Cells during Viral Infection. J Virol (2015) 0.76
Mesenchymal stem cells overexpressing Sirt1 inhibit prostate cancer growth by recruiting natural killer cells and macrophages. Oncotarget (2016) 0.75
Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions. PLoS One (2013) 0.75
Metabolic Regulation of Natural Killer Cell IFN-γ Production. Crit Rev Immunol (2016) 0.75
Mesenchymal stem cells with Sirt1 overexpression suppress breast tumor growth via chemokine-dependent natural killer cells recruitment. Sci Rep (2016) 0.75
Changes of peripheral lymphocyte subsets and cytokine environment during aging and deteriorating gastrointestinal tract health status. Oncotarget (2017) 0.75
Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68
Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature (2005) 7.40
Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci U S A (2002) 5.17
TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity (2004) 4.50
In vivo developmental stages in murine natural killer cell maturation. Nat Immunol (2002) 4.25
Cytokine-induced memory-like natural killer cells. Proc Natl Acad Sci U S A (2009) 3.74
Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol (2002) 3.20
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Nat Immunol (2002) 2.92
Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest (2003) 2.79
Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity (2013) 2.61
Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol (2004) 2.43
HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A (2008) 2.31
Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J Immunol (2002) 2.26
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation. J Clin Invest (2013) 2.21
NKG2D function protects the host from tumor initiation. J Exp Med (2005) 2.19
Escape of mutant double-stranded DNA virus from innate immune control. Immunity (2004) 2.14
Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol (2007) 2.12
Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol (2003) 2.09
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife (2014) 1.97
MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med (2010) 1.95
Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J Exp Med (2008) 1.86
Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol (2011) 1.85
Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol (2005) 1.85
Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc Natl Acad Sci U S A (2003) 1.85
Induction of natural killer cell responses by ectromelia virus controls infection. J Virol (2007) 1.62
2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog (2012) 1.62
Hidden talents of natural killers: NK cells in innate and adaptive immunity. EMBO Rep (2009) 1.60
Natural killer cell tolerance licensing and other mechanisms. Adv Immunol (2009) 1.60
Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol (2005) 1.55
Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol (2005) 1.53
Structural mechanism of ER retrieval of MHC class I by cowpox. PLoS Biol (2012) 1.49
Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe (2009) 1.48
Ly49E-dependent inhibition of natural killer cells by urokinase plasminogen activator. Blood (2008) 1.45
Role of natural killer cells in innate protection against lethal ebola virus infection. J Exp Med (2004) 1.44
MHC Class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358: 66-70, 1992. J Immunol (2006) 1.43
Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. J Immunol (2005) 1.42
Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol (2009) 1.40
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med (2004) 1.35
Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D. J Exp Med (2007) 1.34
Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production. Blood (2008) 1.34
IFN-dependent down-regulation of the NKG2D ligand H60 on tumors. J Immunol (2006) 1.31
Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity (2009) 1.29
Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe (2007) 1.27
Costimulation of multiple NK cell activation receptors by NKG2D. J Immunol (2002) 1.27
A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection. PLoS Pathog (2011) 1.26
DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J Immunol (2006) 1.26
Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol (2010) 1.24
Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J Immunol (2004) 1.19
Natural killer cells and autoimmunity. Arthritis Res Ther (2003) 1.14
Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. J Virol (2006) 1.13
Ly49h is necessary for genetic resistance to murine cytomegalovirus. Immunogenetics (2008) 1.12
Memory-like responses of natural killer cells. Immunol Rev (2010) 1.11
Streptolysin O clearance through sequestration into blebs that bud passively from the plasma membrane. J Cell Sci (2011) 1.11
Natural killer cells in human autoimmune disorders. Arthritis Res Ther (2013) 1.10
Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta. J Leukoc Biol (2004) 1.10
Mechanisms involved in synergistic anticancer immunity of anti-4-1BB and anti-CD4 therapy. Cancer Res (2007) 1.08
Stability of murine cytomegalovirus genome after in vitro and in vivo passage. J Virol (2009) 1.08
Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc Natl Acad Sci U S A (2012) 1.08
IL-18 acts synergistically with IL-15 in stimulating natural killer cell proliferation. Cytokine (2006) 1.07
Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Nat Immunol (2012) 1.05
A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice. J Immunol (2002) 1.04
Arrested natural killer cell development associated with transgene insertion into the Atf2 locus. Blood (2005) 0.99
Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming. Proc Natl Acad Sci U S A (2012) 0.99
Ly49H+ NK cells migrate to and protect splenic white pulp stroma from murine cytomegalovirus infection. J Immunol (2008) 0.96
Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J Immunol (2007) 0.96
NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function. J Immunol (2006) 0.95
DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo. Eur J Immunol (2009) 0.93
NK cell tolerance and the maternal-fetal interface. Am J Reprod Immunol (2008) 0.93
The gp49B1 inhibitory receptor regulates the IFN-gamma responses of T cells and NK cells. J Immunol (2003) 0.92
NKG2D-independent suppression of T cell proliferation by H60 and MICA. Proc Natl Acad Sci U S A (2005) 0.92
Murine cytomegalovirus protein pM79 is a key regulator for viral late transcription. J Virol (2013) 0.92
Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer. Cancer Res (2012) 0.92
Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci U S A (2013) 0.90
Rapid emergence of escape mutants following infection with murine cytomegalovirus in immunodeficient mice. Clin Immunol (2005) 0.89
Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands. J Immunol (2011) 0.88
Development of thymic NK cells from double negative 1 thymocyte precursors. Blood (2011) 0.87
Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol (2003) 0.86
Recognition of infected cells by natural killer cells. Curr Opin Immunol (2004) 0.86
Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis. J Clin Invest (2016) 0.86
Contrasting roles of the IL-1 and IL-18 receptors in MyD88-dependent contact hypersensitivity. J Invest Dermatol (2010) 0.85
Evidence for high bi-allelic expression of activating Ly49 receptors. Nucleic Acids Res (2009) 0.84
Flow cytometry analysis using the Becton Dickinson FACS Calibur. Curr Protoc Immunol (2002) 0.84
Molecular genetic characterization of the distal NKC recombination hotspot and putative murine CMV resistance control locus. Immunogenetics (2003) 0.83
Reduction of streptolysin O (SLO) pore-forming activity enhances inflammasome activation. Toxins (Basel) (2013) 0.83
Distal-less homeobox transcription factors regulate development and maturation of natural killer cells. Proc Natl Acad Sci U S A (2008) 0.83
Cowpox virus employs a two-pronged strategy to outflank MHCI antigen presentation. Mol Immunol (2013) 0.82
Inositol tetrakisphosphate limits NK cell effector functions by controlling PI3K signaling. Blood (2012) 0.82
Assessing licensing of NK cells. Methods Mol Biol (2010) 0.81
Corrigendum: Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature (2015) 0.81
Chronic lymphocytosis of functionally immature natural killer cells. J Allergy Clin Immunol (2007) 0.81
Primary naive and interleukin-2-activated natural killer cells do not support efficient ectromelia virus replication. J Gen Virol (2008) 0.81
Isolation of murine natural killer cells. Curr Protoc Immunol (2014) 0.80
Murine trophoblast cells induce NK cell interferon-gamma production through KLRK1. Biol Reprod (2010) 0.78
Chronic allergic contact dermatitis promotes skin cancer. J Clin Invest (2014) 0.77
Contact hypersensitivity: not just T cells! Nat Immunol (2006) 0.77
Regulation of the NK cell alloreactivity to bone marrow cells by the combination of the host NK gene complex and MHC haplotypes. J Immunol (2008) 0.77
Innate immunity to pathogens. Curr Opin Immunol (2008) 0.75
Immunology: catch us if you can. Nature (2002) 0.75
Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression. Immunity (2017) 0.75